USANA Health Sciences Inc. - 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended September 29, 2001, and the nine-month period ended on the same date. USANA Health Sciences, Inc. develops and manufactures nutritional, personal care, and weight management products distributed via a network marketing system of independent "Associates" and a "Preferred Customer" program. As of the period end, the company had approximately 84,000 Associates and 81,000 Preferred Customers globally.
Key Financial Metrics
| Metric (in thousands) | Quarter Ended Sep 29, 2001 | Nine Months Ended Sep 29, 2001 |
|---|---|---|
| Net Sales | $29,341 | $85,561 |
| Gross Profit | $21,109 (71.9% margin) | $60,993 (71.3% margin) |
| Net Earnings | $586 | $1,551 |
| Diluted EPS | $0.06 | $0.16 |
| Cash and Equivalents | $4,105 | $4,105 (Ending Balance) |
| Operating Cash Flow | N/A | $8,773 |
| Total Debt (Current + Long-term) | $13,808 | $13,808 (Ending Balance) |
| Net Working Capital | ($773) | N/A |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 3.4% for the quarter and 8.5% for the nine months compared to the prior year. This was driven by a 15% reduction in the Associate base, weaker foreign currencies, and a "value initiative" that reduced product prices by an average of 24%.
- Profitability: Despite lower sales, net earnings increased 20% for the quarter ($586k vs $488k) due to reduced cost of goods sold, lower interest expense, and decreased foreign currency losses. However, nine-month net earnings declined 31% ($1.55M vs $2.27M).
- Expense Management: Selling, general, and administrative (SG&A) expenses decreased in absolute terms by $611,000 for the quarter and $823,000 for the nine months, excluding costs related to the new Japanese market.
- Liquidity Shift: The company moved from positive net working capital of $2.3 million in late 2000 to negative net working capital of $773,000 by September 2001, primarily due to capital investments and debt restructuring.
Outlook, Risks, and Management Commentary
- Japan Expansion: The company is investing heavily in a new direct export program in Japan, which opened in October 2001. Management expects SG&A expenses to remain pressured in the remainder of 2001 due to these expansion costs.
- September 11 Impact: The company reported no loss of employees or assets due to the terrorist attacks. However, U.S. air delivery shutdowns caused temporary delays in product orders. Sales slowed immediately post-attack but returned to normal by the end of September.
- Capital Resources: USANA maintains a $12.5 million revolving line of credit (with $5.8 million outstanding) and an $8.0 million term loan. Management believes current cash and credit facilities are sufficient for foreseeable needs, though future expansion may require additional financing.
- Risks: Key risks include high Associate turnover, reliance on network marketing, foreign currency fluctuations (with no hedging instruments currently in place for major currencies), and regulatory scrutiny of the industry.
Investor Verification Checklist
- Associate Base Stability: Verify the trend of the 15% decline in the Associate base and whether the growth in Preferred Customers (up 14%) is sufficient to offset this loss long-term.
- Japan ROI: Monitor the return on the significant capital expenditures ($6.4M in nine months) and SG&A spending allocated to the new Japanese market.
- Working Capital: Investigate the causes and sustainability of the shift to negative net working capital.
- Currency Exposure: Assess the impact of a strengthening U.S. dollar on future earnings, given the lack of hedging instruments for significant foreign currency exposures.
- Debt Covenants: Confirm continued compliance with restrictive covenants on the $25 million credit facility.